Information:
Error:
Description:
NSABP PROTOCOL B-38Treatment Form for Group 2 - Doxorubicin, Cyclophosphamide Followed by Paclitaxel (DD AC - P) - Form T2 NCT00093795 Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD882133-10FD-25D3-E034-0003BA12F5E7
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DD882133-10FD-25D3-E034-0003BA12F5E7Keywords:
Versions (3)
- 12/18/14 12/18/14 - Martin Dugas
- 1/9/15 1/9/15 - Martin Dugas
- 6/16/15 6/16/15 -
Uploaded on:
June 16, 2015
DOI:
To request one please log in.License :
Creative Commons BY-NC 3.0 LegacyModel comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
NSABP PROTOCOL B-38Treatment Form for Group 2 - Doxorubicin, Cyclophosphamide Followed by Paclitaxel (DD AC - P) - Form T2 NCT00093795
No Instruction available.
- StudyEvent: NSABP PROTOCOL B-38Treatment Form for Group 2 - Doxorubicin, Cyclophosphamide Followed by Paclitaxel (DD AC - P) - Form T2